Publication | Closed Access

Retinoid/arsenic combination therapy of promyelocytic leukemia: induction of telomerase-dependent cell death

Hematological MalignancyPromyelocytic LeukemiaMedicineMixed-phenotype Acute LeukemiaMalignant Blood DisorderPathologyCell DeathRetinoid/arsenic Combination TherapyTelomerase-dependent Cell DeathAdult T-cell Leukemia-lymphomaOncologyCell BiologyCancer ResearchMyeloid Neoplasia